Abstract
The amphetamine-derived designer drugs have been illegally used worldwide as recreational drugs, some of which are known to be hepatotoxic in humans. To compare their cytotoxic effects, 3,4-methylenedioxy-N-methamphetamine (MDMA) and its related analogues, N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB), 3,4-(methylenedioxyphenyl)-2-butanamine (BDB) and 2-methylamino-1-(3,4-methylenedioxyphenyl)-propane-1-one (methylone) were studied in freshly isolated rat hepatocytes. MBDB caused not only concentration (0–4.0 mM)- and time (0–2 h)-dependent cell death accompanied by the formation of cell blebs, and the loss of cellular ATP and adenine nucleotide pools, and reduced glutathione levels, but also the accumulation of oxidized glutathione. Of the other analogues examined, the cytotoxicity of MBDB and BDB was greater than that of MDMA and methylone, suggesting that hepatotoxicity is generally induced by these drugs. In addition, DNA damage and the induction of reactive oxygen species were greater after the incubation of hepatocytes with MBDB (2 and 4 mM) than after that with MDMA. In isolated liver mitochondria, MBDB/BDB resulted in a greater increase in the rate of state 4 oxygen consumption than did MDMA/methylone, indicating an uncoupling effect and a decrease in the rate of state 3 oxygen consumption in a concentration dependent manner. Furthermore, MBDB resulted in mitochondrial swelling dependent on the mitochondrial permeability transition (MPT); the effect of MDMA was less than that of MBDB. Taken collectively, these results suggest that (1) the onset of cytotoxicity caused by designer drugs such as MBDB and MDMA is linked to mitochondrial failure dependent upon the induction of the MPT accompanied by mitochondrial depolarization and depletion of ATP through uncoupling of oxidative phosphorylation in rat hepatocytes, and (2) MBDB and MDMA elicit DNA damage, suggesting that nuclei as well as mitochondria are target sites of these compounds.
Similar content being viewed by others
Abbreviations
- MDMA:
-
3,4-Methylenedioxy-N-methamphetamine
- MBDB:
-
N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine
- BDB:
-
3,4-(Methylenedioxyphenyl)-2-butanamine
- Methylone:
-
2-Methylamino-1-(3,4-methylenedioxyphenyl)propane-1-one
- DMSO:
-
Dimethyl sulfoxide
- GSH:
-
Glutathione reduced form
- GSSG:
-
Glutathione oxidized form
- MPT:
-
Mitochondrial permeability transition
- ROS:
-
Reactive oxygen species
References
Andreu V, Mas A, Bruguera M, Salmerón JM, Moreno V, Nogué S, Rodés J (1998) Ecstasy: a common cause of severe acute hepatotoxicity. J Hepatol 29:394–397
Arora AS, Jones BJ, Patel TC, Bornk SF, Gores GJ (1997) Ceramide induces hepatocytes cell death through disruption of mitochondrial function in the rat. Hematology 25:958–963
Beitia G, Cobreros A, Sainz L, Cenarruzabeitia E (1999) 3, 4-Methylenedioxy-methamphetamine (ecstasy)-induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes. Liver 19:234–241
Bellomo G, Mirabelli F, Richelmi P, Malorni W, Iosi F, Orrenius S (1990) The cytoskeleton as a target in quinone toxicity. Free Radic Res Commun 8:391–399
Bosser BG, Gores GJ (1995) Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology 108:252–275
Bronson ME, Jiang W, DeRuiter J, Clark CR (1995) Structure–activity relationships of BDB and its monomethyl and dimethyl derivatives. Pharmacol Biochem Behav 51:477–479
Brown JM, Yamamoto BK (2003) Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol Thera 99:45–53
Cain K, Skilleter DS (1987) Preparation and use of mitochondria in toxicological research. In: Snell K, Mullock B (eds) Biochemical toxicology, a practical approach. IRL Press, Oxford, pp 217–254
Capela JP, Meisel A, Abreu AR, Branco PS, Ferreira LM, Lobo AM, Remiao F, Bastos ML, Carvalho F (2006) Neurotoxicity of ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. J Pharmacol Exp Ther 316:53–61
Carvalho M, Hawksworth G, Milhazes N, Borges F, Monks TJ, Fernandes E, Carvalho F, Bastos ML (2002) Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells. Arch Toxicol 76:581–588
Carvalho M, Milhazes N, Remião F, Borges F, Fernandes E, Amado F, Monks TJ, Carvalho F, Bastos ML (2004a) Hepatotoxicity of 3, 4-methylenedioxy-amphetamine α-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates. Arch Toxicol 78:16–24
Carvalho M, Remião F, Milhazes N, Borges F, Fernandes E, Carvalho F, Bastos ML (2004b) The toxicity of N-methyl-α-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine. Toxicology 200:193–203
Dar KJ, McBrien ME (1996) MDMA induced hyperthermia: report of a fatality and review of current therapy. Intensive Care Med 22:995–996
Davidson C, Gow AJ, Lee TH, Ellinwood EH (2001) Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Rev 36:1–22
Fusi F, Sgaragli G, Murphy MP (1992) Interaction of butylated hydroxyanisole with mitochondrial oxidative phosphorylation. Biochem Pharmacol 43:1203–1208
Glennon RA, Young R, Martin BR, Dal Cason TA (1995) Methcathione (“cat”): an enantiomeric potency comparison. Pharmacol Biochem Behav 50:601–606
Griffiths EJ, Halestrap AP (1995) Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 307(pt 1):93–98
Gunter TE, Pfeiffer DR (1990) Mechanism by which mitochondria transport calcium. Am J Phys 258(5 pt 1):C755–C786
Hall AP, Henry JA (2006) Acute toxic effects of ‘Ecstasy’ (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth 96:678–685
Hartmann A, Kiskins E, Fjällman A, Suter W (2001) Influence of cytotoxicity and compound precipitation on test results in the alkaline comet assay. Mutat Res 497:199–212
Hegadoren KM, Baker GB, Bourin M (1999) 3, 4-Methylenedioxy analogues of amphetamine: defining the risks to humans. Neurosci Biobehav Rev 23:539–553
Henry JA, Jeferey KJ, Dawling S (1992) Toxicity and deaths from 3, 4-methylenedioxymethanphetamine (“ecstasy”). Lancet 340:384–387
Hinshaw DB, Sklar LA, Bohl B, Schraufstatter LU, Rossi MW, Spragg RG, Cochrane CG (1986) Cytoskeletal and morphological impact of cellular oxidant injury. Am J Pathol 123(3):454–464
Hiramatsu M, Kumagai Y, Unger SE, Cho AK (1990) Metabolism of methylenedioxymethamphetamine and a quinone identified as its glutathione adduct. J Pharmacol Exp Ther 254:521–527
Huang X, Frenkel K, Klein CB, Costa M (1993) Nickel induces increased oxidants in intact cultured mammalian cells as detected by dichlorofluorescein fluorescence. Toxicol Appl Pharmacol 120:29–36
Jacob PIII, Shulgin AT (1994) Structure-activity relationships of the classic hallucinogens and their analogs. Natl Inst Drug Abuse Res Monogr Ser Res Monogr 146:74–91
Jones DP (1981) Determination of pyridine dinucleotides in cell extracts by high-performance liquid chromatography. J Chromatogra 225:446–449
Jones AL, Simpson J (1999) Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications. Aliment Pharmacol Ther 13:129–133
Kamata H, Shima N, Zaitsu K, Kamata T, Miki A, Nishikawa, Katagi M, Tsuchihashi H (2006) Metabolism of the recently encountered designer drug, methylone, in humans and rats. Xenobiotica 36: 709–723
Kehrer JP, Jones DP, Lemasters JJ, Farber H, Jaeschke H (1990) Mechanisms of hypoxic cell injury. summary of the symposium presented at the 1990 annual meeting of the Society of Toxicology. Toxicol Appl Pharmacol 106:165–178
Kroemer G (1999) Mitochondrial control of apoptosis: an overview. Biochem Soc Symp 66:1–15
Lemasters JJ, Nieminen AL, Chacon E, Imberti R, Gores G, Reece JM, Herman B (1993) Use of fluoresencet probes to monitor mitochondrial membrane potential in isolated mitochondria, cell suspensions, and cultured cells. In: Lash LH, Jones DP (eds) Mitochondrial dysfunction. Academic Press, San Diego, pp 404–415
Lemasters JJ, Nieminen AL, Qian T, Trost LC, Herman B (1997) The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury. Mol Cell Biochem 174:159–165
Lin LY, Kumagai Y, Cho AK (1992) Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes. Chem Res Toxicol 5:401–406
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Milroy CM, Clark JC, Forrest AR (1996) Pathology of deaths associated with “ecstasy” and “eve” misuse. J Clin Pathol 49:149–153
Moldéus P, Hogberg J, Orrenius S (1978) Isolation and use of liver cells. Meth Enzymol 52:60–71
Nakagawa Y, Tayama S, Ogata A, Suzuki T, Ishii H (2006) ATP-generating glycolytic substrates prevent N-nitrosofenfluramine-induced cytotoxicity in isolated rat hepatocytes. Chem Biol Interact 164:93–101
Nakagawa Y, Moore G (1999) Role of mitochondrial membrane permeability transition in p-hydroxybenzoate ester-induced cytotoxicity in rat hepatocytes. Biochem Pharmacol 58:811–816
Nakagawa Y, Moldéus P (1998) Mechanism of p-hydroxybenzoate ester-induced mitochondrial dysfunction and cytotoxicity in rat hepatocytes. Biochem Pharmacol 55:1907–1914
Nichols DE (1986) Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoactive Drugs 18:305–313
Nicotera P, Bellomo G, Orrenius S (1992) Calcium-mediated mechanisms in chemically induced cell death. Ann Rev Pharmacol Toxicol 32:447–470
Ninković M, Malicević Z, Selaković V, Simić I, Vasiljević I (2004) N-methyl-3, 4-methylenedioxyamphetamine-induced hepatotoxicity in rats: oxidative stress after acute and chronic administration. Vojnosanit Pregl 61:125–131
Petronilli V, Constantini P, Scorrano L, Colonna R, Passamonti S, Bermardi P (1994) The voltage sensor of the mitochondrial permeability transition pore is turned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidation and its reversal by reducing agents. J Biol Chem 269:16638–16642
Reed DJ, Babson JR, Beatty PW, Brodie AE, Ellis WW, Potter DW (1980) High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide and related thiols and disulfides. Anal Biochem 106:55–62
Shen H-M, Shi C-Y, Shen Y, Ong C-N (1996) Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1. Free Radic Biol Med 21:139–146
Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryn J-C, Sasaki YF (2000) Single cell gell/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206–221
Trost LC, Lemasters JJ (1996) The mitochondrial permeability transition new pathophysiological mechanism if Reye’s syndrome and toxic lover injury. J Pharmcol Exp Ther 278:1000–1005
Walker TM, Davenport-Jones JE, Fox RM, Atterwill CK (1999) The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its metabolites on rat brain spheroids in culture. Cell Biol Toxicol 15:137–142
Wallace KB, Eells JT, Madeira VM, Cortopassi G, Jones DP (1997) Mitochondria-mediated cell injury. Symposium overview. Fundam Appl Toxicol 38:23–37
Walubo A, Seger D (1999) Fatal multi-organ failure after suicidal overdose with MDMA, ‘ecstasy’: case report and review of the literature. Hum Exp Toxicol 18:119–125
Wang H, Joseph JA (1999) Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 27:612–616
Zalis EG, Lundberg GD, Knutson RA (1967) The pathophysiology of acute amphetamine poisoning with pathologic correlation. J Pharmacol Exp Ther 158:115–127
Zhang JG, Tirmenstein MA, Nicholls-Grzemski FA, Fariss MW (2001) Mitochondrial electron transport inhibitors cause lipid peroxidation-dependent and -independent cell death: protective role of antioxidants. Arch Biochem Biophys 393:87–96
Acknowledgments
The authors thank Dr. Ichirou Yasuda and his colleagues for providing MDMA and its analogues.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakagawa, Y., Suzuki, T., Tayama, S. et al. Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes. Arch Toxicol 83, 69–80 (2009). https://doi.org/10.1007/s00204-008-0323-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-008-0323-9